Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Temsirolimus in Recurrent Malignant Glioma
NCT00112736Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2005
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, temsirolimus in malignant glioma, sponsored by National Cancer Institute. Started Apr 2005; status: completed.
02
Drugs
erlotinibtemsirolimus
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00112736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112736.